CKD患者由于净酸排泄受损(NAE)而处于代谢性酸中毒的高风险中。确定酸中毒的早期标志物可以指导慢性肾脏疾病(CKD)的预防。这项研究比较了有和没有CKD的参与者的NAE,以及NAE,血压(BP),和代谢组学对碳酸氢盐补充的反应。
随机顺序,控制喂养的交叉研究。
参与者包括8例CKD患者(估计肾小球滤过率30-59mL/min/1.73m2或60-70mL/min/1.73m2伴蛋白尿)和6例无CKD患者。所有参与者的基线血清碳酸氢盐浓度在20和28mEq/L之间;他们没有糖尿病,也没有在基线时使用碱补充剂。
参与者按随机顺序喂食固定酸负荷的饮食,补充碳酸氢盐(7天)和氯化钠对照(7天)。跨越时尚。
尿液NAE,24小时动态血压,在每个时期后测量24小时尿液和血浆代谢组学谱。
在控制期间,平均NAE为28.3±10.2mEq/d,组间无差异(P=0.5).尿液pH值,铵,CKD和柠檬酸盐明显低于非CKD(P<0.05)。补充碳酸氢盐可降低CKD组的NAE和尿铵,两组的尿液pH值都升高(但CKD患者的尿液pH值高于非CKD患者),和增加;CKD组的尿柠檬酸盐(每种相互作用P<0.2)。代谢组学分析显示,CKD中几种尿液有机阴离子随碳酸氢盐增加,包括3-吲哚乙酸酯,柠檬酸盐/异柠檬酸盐,和戊二酸。BP无明显变化。
样本量小,饲喂时间短。
与没有CKD的患者相比,那些与CKD有较低的酸排泄形式的铵,但也较低的碱排泄,如柠檬酸盐和其他有机阴离子,保持酸碱稳态的潜在补偿。在CKD,酸排泄进一步减少,但基础排泄(例如,柠檬酸盐)对碱的反应增加。应将尿柠檬酸盐评估为酸碱稳态受损的早期和响应性标志物。
国家糖尿病、消化和肾脏疾病研究所和杜克大学奥布赖恩肾脏研究中心。
在ClinicalTrials.gov注册,研究编号为NCT02427594。
Patients with CKD are at elevated risk of metabolic acidosis due to impaired net acid excretion (NAE). Identifying early markers of acidosis may guide prevention in chronic kidney disease (CKD). This study compared NAE in participants with and without CKD, as well as the NAE, blood pressure (BP), and metabolomic response to bicarbonate supplementation.
Randomized order, cross-over study with controlled feeding.
Participants consisted of 8 patients with CKD (estimated glomerular filtration rate 30-59mL/min/1.73m2 or 60-70mL/min/1.73m2 with albuminuria) and 6 patients without CKD. All participants had baseline serum bicarbonate concentrations between 20 and 28 mEq/L; they did not have diabetes mellitus and did not use alkali supplements at baseline.
Participants were fed a fixed-acid-load diet with bicarbonate supplementation (7 days) and with sodium chloride control (7 days) in a randomized order, cross-over fashion.
Urine NAE, 24-hour ambulatory BP, and 24-hour urine and plasma metabolomic profiles were measured after each period.
During the control period, mean NAE was 28.3±10.2 mEq/d overall without differences across groups (P=0.5). Urine pH, ammonium, and citrate were significantly lower in CKD than in non-CKD (P<0.05 for each). Bicarbonate supplementation reduced NAE and urine ammonium in the CKD group, increased urine pH in both groups (but more in patients with CKD than in those without), and increased; urine citrate in the CKD group (P< 0.2 for interaction for each). Metabolomic analysis revealed several urine organic anions were increased with bicarbonate in CKD, including 3-indoleacetate, citrate/isocitrate, and glutarate. BP was not significantly changed.
Small sample size and short feeding duration.
Compared to patients without CKD, those with CKD had lower acid excretion in the form of ammonium but also lower base excretion such as citrate and other organic anions, a potential compensation to preserve acid-base homeostasis. In CKD, acid excretion decreased further, but base excretion (eg, citrate) increased in response to alkali. Urine citrate should be evaluated as an early and responsive marker of impaired acid-base homeostasis.
National Institute of Diabetes and Digestive and Kidney Diseases and the Duke O\'Brien Center for Kidney Research.
Registered at ClinicalTrials.gov with study number NCT02427594.